CN1490036A - Chemical for promoting growth of hairs and preventnig sinility - Google Patents
Chemical for promoting growth of hairs and preventnig sinility Download PDFInfo
- Publication number
- CN1490036A CN1490036A CNA031345220A CN03134522A CN1490036A CN 1490036 A CN1490036 A CN 1490036A CN A031345220 A CNA031345220 A CN A031345220A CN 03134522 A CN03134522 A CN 03134522A CN 1490036 A CN1490036 A CN 1490036A
- Authority
- CN
- China
- Prior art keywords
- oil
- medicine
- hair
- poliosis
- leaf oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001737 promoting effect Effects 0.000 title claims description 7
- 210000004209 hair Anatomy 0.000 title abstract description 14
- 239000000126 substance Substances 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 241000229143 Hippophae Species 0.000 claims description 35
- 235000003935 Hippophae Nutrition 0.000 claims description 25
- 230000037308 hair color Effects 0.000 claims description 16
- 230000003779 hair growth Effects 0.000 claims description 5
- 230000002605 anti-dotal effect Effects 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 23
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 3
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 16
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 201000004384 Alopecia Diseases 0.000 description 6
- 231100000360 alopecia Toxicity 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000003646 hair health Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical group C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 2
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for growing and blackening hair and delaying senility is prepared from the oil of seabuckthorn fruit and leaf. Its advantages are high curative effect and high safety.
Description
Technical field
The invention belongs to the medicine of treatment alopecia, poliosis, and with health role.
Background technology
Alopecia, poliosis symptom cause of disease complexity.Except that heredity, the Nervous and Mental Factors, research both at home and abroad thinks, and is how relevant with nutriture and endocrine, particularly with to urge gonad relevant with the adrenocorticotropin function in the body.Poliosis patient's the copper number of sending out all is lower than the hair color group in addition, and lacks elements such as calcium, magnesium, strontium, lead and zinc.Treat so far alopecia, poliosis in, western drug is more, comprises some Chinese medicine proved recipes, folk prescription and patent.Black hair such as employing Semen Sesami Nigrum for example among the people, Semen sojae atricolor, Radix Polygoni Multiflori, Fructus Mori.Patent such as ZL98114250, ZL94100306 etc., the Chinese medicine ingredients that these medicines relate to is all more, mainly plays the promoting blood circulation to remove obstruction in the collateral effect, fails effectively to treat at the real cause of disease of alopecia.Therefore treatment cycle is long, and curative effect is not remarkable, and has repeatedly.Often nearly tens kinds of Chinese medicine ingredients that existing various kinds of drug relates to, and contain the composition of many rare costlinesses, patient's difficulty of making up a prescription, financial burden is heavier.The some of them medicine also has side effect.In a word, existing various kinds of drug is neither enough desirable to the therapeutic effect of additional issue, black hair, still do not have at present a kind of efficiently, safely, the medicine of simplifying.
Summary of the invention
The objective of the invention is to avoid the above-mentioned deficiency of existing therapy, from endocrine regulation with improve nutriture and start with, a kind of hair growth promoting, hair color of better effects if is provided and has the medicine of health care concurrently.
The inventor specializes in the pharmacological research of seabuckthorn plant fruit oil and leaf oil all the year round.Once in Chinese patent ZL94118300, proposed with Oleum Hippophae as the medicine of regulating endocrine function of woman.Evidence, this medicine be to treatment climacteric syndrome, premature ovarian failure, and premenstrual syndrome and thyroid are hyperfunction etc. remarkable result.Through identifying, now become very popular counter proprietaries.The inventor is through clinical experiment for many years and observe to find, taking Oleum Hippophae not only all has in various degree improvement to the women but also to male's hair, and originally the thin hair change is close, and poliosis becomes hair color gradually.A large amount of evidences, Oleum Hippophae and leaf oil truly have the effect of additional issue, hair color, and have defying age and the effect of lengthening the life.
For this reason, the present invention proposes the fruit oil and/or the application of leaf oil in preparation hair growth promoting, hair color and antidotal medicine of seabuckthorn plant.The main component of this medicine is the fruit oil and/or the leaf oil of seabuckthorn plant.
This medicine can be simple Oleum Hippophae or leaf oil, also they can be mixed and use.Wherein also can contain other medicines compositions such as Semen Sesami Nigrum oil or Radix Polygoni Multiflori, all belong to protection scope of the present invention.
Above-mentioned Oleum Hippophae and leaf oil both can have been distinguished use separately, also can mix use by a certain percentage.Preferable weight proportion is: Oleum Hippophae: leaf oil=1: 0.9～1.1.
Above-mentioned said each composition can be made soft capsule, also can be made into dosage forms such as oral liquid.
The mechanism of action that the present invention treats poliosis may be that Oleum Hippophae, leaf oil can regulate vegetative nerve function, promotes the metabolism of catecholamine, thereby stops the activity of melanin tryrosinase to reduce, and stops the generation of poliosis; Oleum Hippophae, leaf oil can increase melanin stimulation hormone in the body simultaneously, and activate the activity of tryrosinase, thereby stimulate the hair color growth.
Preliminary study thinks, take Oleum Hippophae and/or leaf oil after, make that androgen (T), estrogen (E2) and thyroliberin level (ACTH) change in person in middle and old age's aging body, thereby hair condition improved.Take in addition and can improve health and hair behind this preparation Cu
2+And Ca
2+, Mg
2+, Se
2+Deng absorption, nutriture is improved, thereby activates melanocyte-stimulating hormone simultaneously and the hair root of hair makes the hair blackening.
Oleum Hippophae is the fruit oil of seabuckthorn plant.During extraction, sea-buchthorn fresh fruit is placed dull and stereotyped squeezer extracting juice, be pressed in the receiver with 30～80 ℃ of steam heated 30 minutes (to remove the interior water-soluble substances that deoils) through coarse filtration, half fine straining, tank filter is passed through in pressurization again, the pressurization fine straining is 4 times continuously, pressurization at last enters newborn ester butterfly centrifugal machine and separates, and can obtain juice of Fructus Hippophae and fruit oil respectively.The leaf oil of Fructus Hippophae also can separate by similar approach.
For ease of oral and carry, the inventor makes soft capsule with capsule machine with Oleum Hippophae.Oleum Hippophae is closed in the capsule, is the sealing shape, and that fruit oil is difficult for is oxidized, become sour and pollute, and also can be made into oral liquid formulation or other dosage form.Oral liquid matched proportion density oil is advisable with 1: 2～4 with the ratio of water, makes through emulsifying.Oleum Hippophae taking dose every day should be no less than 3ml, and suitably many clothes better effects if are free from side effects.When dosage is lower than 3ml, DeGrain or invalid.Be preferably on an empty stomach and take.When these goods are used as additional issue, hair color medicine, be named primordial essence black hair health bolus, as its trade name.
Up to now, domestic and foreign literature do not have as yet report with Oleum Hippophae or leaf oil as treatment alopecia, poliosis and antidotal medicine.Thereby to utilize this preparation additional issue, hair color be the valuable new discovery of field of medicaments, belongs to the first both at home and abroad.
Seabuckthorn plant belongs to Elaeangnaceae, machaka or dungarunga, and kind is more, is distributed in Asia and other area.Main kind in China is Chinese sea buckthorn and central asian sea buckthorn, generally is distributed in provinces such as northwest, southwest.Fructus Hippophae is born in the arid desert or extremely frigid zones more.This preparation Oleum Hippophae or leaf oil belong to pure galenical.Wherein be rich in the various active material, as vitamin E, C, carotenoid, steroid, total flavones, betanin, steroid, trace element and aminoacid etc.The necessary trace element of present known human body is 14 kinds, just contains 11 kinds more than in the Oleum Hippophae.The aminoacid that also contains A wide selection of colours and designs in the Fructus Hippophae, 8 necessary seed amino acids of human body all contain, and its content is up to aspartic acid, and all the other are followed successively by proline, serine, phenylalanine and lysine etc.This multiple bioactive substance may be the activator of endocrine regulation function, and can significantly improve the endotrophic situation.Tentatively think, fatty acid in the Oleum Hippophae and other active substance produce the endocrine effect that activates in vivo jointly, adjust body inner estrogen (E2), androgen (T), the mutual level of thyroliberin (ACTH), thereby reach the purpose of treatment alopecia, poliosis.
This preparation Oleum Hippophae or leaf oil can directly be taken as the folk prescription medicine, and be easy to be reliable.Compare with dietetic therapy among the people and other method, curative effect is higher, and is safer, without any side effects, can take for a long time, is easy to promote the use of, and is a kind of ideal black hair, additional issue and defying age medicine.The present invention has obviously found new medical application for Oleum Hippophae.
The soft capsule that this research adopts Oleum Hippophae, leaf oil to make is treated juvenile poliosis and gray hair of the middle aged respectively, and all effect is remarkable.Mostly be due to deficiency of YIN heat in blood, the damp stasis according to juvenile poliosis; The gray hair of the middle aged mostly is the hepatic and renal YIN deficiency, caused by energy stagnation and blood stasis, observes teenager group 104 examples respectively, and person in middle and old age organize 103 examples, and its efficacy result is as follows:
Object and method:
One, young group treatment situation: (one) case is selected; 104 routine young poliosis groups, wherein 18 years old-20 years old 36 examples, 21 years old-25 years old 56 examples, 26 years old-28 years old 12 examples.Case sex: women's 38 examples, male's 66 examples.
(2) Therapeutic Method: oral primordial essence black hair health bolus 0.72g/ ball * 3-20 ball/day, adjust in right amount according to the state of an illness.
(3) efficacy result (seeing Table 1)
Every symptom relatively before and after the young group treatment of table 1
Compare in the group of the preceding test of disease type symptom treatment group test back
N (example)-+++ +++-+++ +++Z P
Wet cloudy irritated irritability 104 7 40 49 8 58 43 3 0-8.119 0.001
Evil empty acne shows effect 104 9 30 47 18 58 30 14 2-7.691 0.001
The stagnation of the blood is hard and dry 104 42 39 20 3 93 83 0-6.627 0.001
Hot red tongue 104 49 36 15 3 88 12 2 1-5.922 0.001 stagnates
Annotate :-asymptomatic+light symptoms ++ the moderate symptom +++severe symptom: relatively, every tcm symptom all has clear improvement before and after the treatment; Relatively be before and after in its group: there is highly significant difference P＜0.001.
The young group treatment of table 2 back poliosis efficacy result
Treatment group n (example) invalid (%) produce effects (%) progressive (%) is (%) effectively
104 7(6.73) 68(65.38) 29(27.89) 93.27
Annotate: invalidly be no newborn hair color, progressive is newborn hair color 〉=30%, and produce effects is a newborn hair color 〉=more than 50%.Effectively=produce effects+progress.
The result shows: primordial essence black hair health bolus is to deficiency of YIN heat in blood, the poliosis that damp stasis causes, improving irritated irritability, the acne outbreak, be hard and dry, tcm symptom aspect effects such as red tongue are obvious, P＜0.001, highly significant difference is arranged. the efficacy result obvious effective rate that the back poliosis of taking medicine improves is 65.3%, and effective percentage is 93.27%.
Two, person in middle and old age organize the treatment situation
(1) case is selected: 103 routine gray hair of the middle aged's groups.Wherein 30 years old-40 years old 12 examples, 41 years old-50 years old 37 examples, 51 years old-60 years old 28 examples, 61 years old-70 years old 26 examples.Case sex: women's 56 examples, male's 47 examples.
(2) Therapeutic Method: oral primordial essence black hair health bolus 0.72g/ * 5-25 ball/day, adjust in right amount according to the state of an illness.
(3) efficacy result
Every symptom relatively before and after table 3 person in middle and old age organized treatment
Compare in the group of the preceding test of disease type symptom treatment group test back
N (example)-+++ +++-+++ +++Z P
Irritated irritability 103 3 45 44 11 56 39 5 3-7.966 0.001
Gas liver waist knee joint acid 103 13 35 45 10 54 41 7 1-7.691 0.001
Kidney dizziness and tinnitus 103 18 46 33 6 71 28 4 0-7.600 0.001 stagnates
The cloudy insomnia 103 58 30 14 1 94 81 0-5.509 0.001 of blood
The stasis of blood empty uncomfortable in chest 103 33 42 24 4 86 15 2 0-6.925 0.001
Forgetful 103 8 30 50 15 29 46 25 3-6.205 0.001
Be hard and dry 103 40 34 25 4 86 14 2 1-6.627 0.001
Skin pruritus 103 49 36 15 3 88 12 2 1-5.922 0.001
Annotate :-asymptomatic+light symptoms ++ moderate symptom moderate +++severe symptom; Relatively, every tcm symptom all has clear improvement before and after the treatment; Relatively be before and after in its group: there is highly significant difference P＜0.001.
Table 4 person in middle and old age organize treatment back poliosis efficacy result
Treatment group (n) example invalid (%) produce effects (%) progressive (%) is (%) effectively
103 5(4.85) 67(65.05) 31(30.09) 95.14
Annotate: invalidly be no newborn hair color, progressively be newborn hair color 〉=30%, produce effects is a newborn hair color 〉=more than 50%, and is effective=produce effects+progress.
The result shows: primordial essence black hair health bolus is to the hepatic and renal YIN deficiency, the poliosis that stagnation of QI blood deficiency causes, improve aspect the body symptom remarkable, as soreness of waist and knee joint, dizziness and tinnitus, insomnia forgetfulness, uncomfortable in chest, to be hard and dry, every tcm symptom improves obviously before and after the skin pruritus treatment, there is highly significant difference P＜0.001.The efficacy result that the back poliosis of taking medicine improves: obvious effective rate 65.05%, effective percentage 95.14%.
Hair growth promoting of this preparation and defying age effect be highly significant also, limit by length, repeats no more.All can enclose at any time as needs.
Claims (3)
1, a kind of hair growth promoting, hair color and antidotal medicine is characterized in that: its main component is the fruit oil and/or the leaf oil of seabuckthorn plant.
2, medicine as claimed in claim 1 is characterized in that the fruit oil of said seabuckthorn plant and leaf oil weight proportion are: Oleum Hippophae: leaf oil=1: 0.9～1.1.
3, medicine as claimed in claim 1 is characterized in that containing Semen Sesami Nigrum oil or Radix Polygoni Multiflori in the fruit oil of said seabuckthorn plant and/or the leaf oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03134522 CN1233374C (en) | 2003-08-27 | 2003-08-27 | Chemical for promoting growth of hairs and preventnig sinility |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03134522 CN1233374C (en) | 2003-08-27 | 2003-08-27 | Chemical for promoting growth of hairs and preventnig sinility |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1490036A true CN1490036A (en) | 2004-04-21 |
| CN1233374C CN1233374C (en) | 2005-12-28 |
Family
ID=34154515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03134522 Expired - Fee Related CN1233374C (en) | 2003-08-27 | 2003-08-27 | Chemical for promoting growth of hairs and preventnig sinility |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1233374C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1759683A4 (en) * | 2004-05-21 | 2009-03-25 | Furusatomura Dev Ct Co Ltd | Scalp and hair-care composition |
| CN101878914A (en) * | 2010-06-28 | 2010-11-10 | 崔晓廷 | Seabuckthorn compound oil combined health care products and preparation method thereof |
| CN105384810A (en) * | 2015-11-25 | 2016-03-09 | 青岛康原药业有限公司 | Preparation method of melanophore hormone |
| CN110478262A (en) * | 2019-09-18 | 2019-11-22 | 赵三虎 | Sea-buckthorn shampoo and preparation method thereof |
| FR3117372A1 (en) * | 2020-12-15 | 2022-06-17 | Basf Beauty Care Solutions France Sas | Cosmetic uses of a Hippophae rhamnoides cake hydrolyzate |
-
2003
- 2003-08-27 CN CN 03134522 patent/CN1233374C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1759683A4 (en) * | 2004-05-21 | 2009-03-25 | Furusatomura Dev Ct Co Ltd | Scalp and hair-care composition |
| CN101878914A (en) * | 2010-06-28 | 2010-11-10 | 崔晓廷 | Seabuckthorn compound oil combined health care products and preparation method thereof |
| CN105384810A (en) * | 2015-11-25 | 2016-03-09 | 青岛康原药业有限公司 | Preparation method of melanophore hormone |
| CN110478262A (en) * | 2019-09-18 | 2019-11-22 | 赵三虎 | Sea-buckthorn shampoo and preparation method thereof |
| FR3117372A1 (en) * | 2020-12-15 | 2022-06-17 | Basf Beauty Care Solutions France Sas | Cosmetic uses of a Hippophae rhamnoides cake hydrolyzate |
| WO2022129750A1 (en) * | 2020-12-15 | 2022-06-23 | Basf Beauty Care Solutions France Sas | Cosmetic uses of a hippophae rhamnoides cake hydrolysate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1233374C (en) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393739A (en) | Crocodile penis composition for enhancing sexual function and tonifying kidney and preparation method thereof | |
| CN103610077A (en) | Sea cucumber capsule | |
| CN1233374C (en) | Chemical for promoting growth of hairs and preventnig sinility | |
| CN1255372A (en) | Moxiburning ointment and its preparing process and application | |
| CN102441111A (en) | Chinese patent medicine for treating infertility and preparation method thereof | |
| CN105709020A (en) | Foot bath powder with folium artemisiae argyi decoction dregs and preparation method thereof | |
| CN101912523A (en) | Traditional Chinese medicine preparation for treating iron-deficiency anemia of children | |
| CN105412563A (en) | Cordyceps sinensis traditional Chinese medicine liquor | |
| CN1836715A (en) | External use medicine for quickly treating herpes zoster | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN112587612A (en) | Oyster-deer penis cream and preparation method thereof | |
| CN1175884C (en) | Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof | |
| CN103211978B (en) | Chinese medicine composition for treating kidney-yang deficiency type aplastic anemia | |
| CN101053629A (en) | Traditional Chinese medicine preparations for treating luteal phase defect sterility | |
| CN1110910A (en) | Slim cosmetics and its prodn. method | |
| CN101239128B (en) | Menstruation-regulating face-nourishing Chinese medicinal composition and preparation thereof | |
| CN101062276A (en) | Chinese medicine composition for treating menostaxis | |
| CN103169853B (en) | Traditional Chinese medicine composition for treating kidney yin deficiency type aplastic anemia | |
| CN103610116A (en) | Preparation method for sea cucumber nutritional capsule | |
| CN102145104A (en) | Chinese medical preparation for treating sterility due to kidney deficiency | |
| CN101066388A (en) | Chinese medicine for treating sterility of dead sperm and its prepn process | |
| CN101716302B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN101129691A (en) | Angelica decoction for treating hernia | |
| CN1628829A (en) | Chinese medicine for treating hypertension, high blood fat and high blood sugar | |
| CN101085179A (en) | Traditional Chinese medicine preparation for treating uremia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160113 Address after: Biochemical building, Xi'an Jiaotong University, No. 76 Yanta West Road, Shaanxi, Xi'an Patentee after: SHAANXI TIANKUI BIOMEDICINE TECHNOLOGY Ltd. Address before: 710082, No. 1, building 32, Cao Yang District, labour South Road, Xi'an, Shaanxi Patentee before: Wang Minda |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20221110 Address after: 311200 Room 403, Floor 4, Building 3, No. 111, Hongxing Road, Economic and Technological Development Zone, Xiaoshan District, Hangzhou, Zhejiang Patentee after: Zhejiang Innovation Wisdom Valley Technology Co.,Ltd. Address before: Biochemical Building of Xi'an Jiaotong University, No. 76, Yanta West Road, Xi'an Patentee before: SHAANXI TIANKUI BIOMEDICINE TECHNOLOGY Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051228 |